Clinical Trial for Zebinix (Eslicarbazepine Acetate) in Healthy Korean and Caucasian Adult

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
A dose randomized, double-blind, placebo controlled, single and multiple dosing, dose-escalation phase I clinical trial to investigate the safety, tolerability and pharmacokinetic characteristics of Zebinix (Eslicarbazepine acetate) after oral administration in healthy Korean and Caucasian adult subjects
Epistemonikos ID: 87587212517f0b13ff98eba11161aa8c77fd8639
First added on: May 22, 2024